Skip to content

Ayurvedic intervention to regulate prolonged interval between two menstrual cycles

Efficacy of Vachadi gana ghan vati versus Lasunadi vati in the management of Artvakshaya (Oligomenorrhoea) in overweight women- an open label randomized comparative clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/066768
Enrollment
72
Registered
2024-05-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N915- Oligomenorrhea, unspecified

Interventions

None listed

Sponsors

Dr Monika Kaushik
Lead Sponsor
Shri Dhanwantary Ayurvedic College andHospital
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Female patients of age group between 18 to 40 years Married and Unmarried females Interval of menstrual cycles 38 to 90 days in the past 2 cycles or less than 8 menstrual periods in one year Oligomenorrhoea associated with pelvic pain Oligomenorrhoea associated with Hypomenorrhea BMI 25 to 29.9 associated with normal or increased Waist Hip ratio Diagnosed patients of PCOD with cycle interval of less than 90 days

Exclusion criteria

Exclusion criteria: Female patients below 18 years and above 40 years Hyperthyroidism and uncontrolled Hypothyroidism Patient taking any other kind of medication from three months before treatment or taking presently BMI less than 25 and more than 29.9 Hyperprolactinemia History of Heavy menstrual bleeding more than 80ml per day or more than 7 days in the last 2 cycles which is assessed by PBAC score Patients having any history of diabetes mellitus hypertension Patients with any kind of congenital disease Patients having any pelvic pathologies like uterine fibroid adenomyosis endometriosis PIDs etc

Design outcomes

Primary

MeasureTime frame
Reduction in inter menstrual interval and Reduction in body weightTimepoint: at baseline and after 90 days

Secondary

MeasureTime frame
Reduction in values of triglycerides cholesterol LDL testosterone levels and Changes in waist-hip ratio and changes in other associated symptoms like amount of bleeding and pelvic pain and Conception in case of InfertilityTimepoint: at baseline and after 90 days

Countries

India

Contacts

Public ContactDr Monika Kaushik

Shri Dhanwantary Ayurvedic College and Hospital

archanas875@gmail.com9447767909

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026